| Bioactivity | THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1]. |
| Name | THR-β agonist 3 |
| CAS | 2656400-84-7 |
| Formula | C29H32ClO5P |
| Molar Mass | 526.99 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li Peng, et al. Benzo-fused ring compounds. Patent WO2021129827A1. |
THR-β agonist 3
CAS: 2656400-84-7 F: C29H32ClO5P W: 526.99
THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic disease
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.